Oncolytics Biotech (ONCY) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.55, +1.85% vs the prior close of $0.54.
- Volume 1.30M shares, 1.2x its 50-day average.
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
ONCY rises 1.9% to $0.55, 3 up days in a row. Closed at $0.55, +1.85% vs the prior close of $0.54. Day range $0.52–$0.59, opened at $0.55.
ONCY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ONCY rises 1.9% to $0.55, 3 up days in a row
- Closed at $0.55, +1.85% vs the prior close of $0.54. Day range $0.52–$0.59, opened at $0.55.
- Volume was 1.30M shares, 1.2x its 50-day average of 1.07M.
- Price is -25.9% vs its 50-day average ($0.74) and -38.2% vs its 200-day average ($0.89).
- 52-week range $0.44–$1.32; today's close sits at 13% of that range, 58.3% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — ONCY jumps 10.2% to $0.54 on 3.1x normal volume
- Closed at $0.54, +10.20% vs the prior close of $0.49. Day range $0.44–$0.56, opened at $0.50.
- Volume was 3.15M shares, 3.1x its 50-day average of 1.02M — unusually heavy trading.
- Price is -27.7% vs its 50-day average ($0.75) and -39.5% vs its 200-day average ($0.89).
- 52-week range $0.44–$1.32; today's close sits at 11% of that range, 59.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — ONCY jumps 4.3% to $0.49 on 4.4x normal volume
- Closed at $0.49, +4.26% vs the prior close of $0.47. Day range $0.45–$0.50, opened at $0.49.
- Volume was 4.20M shares, 4.4x its 50-day average of 954.19K — unusually heavy trading.
- Price is -34.9% vs its 50-day average ($0.75) and -45.2% vs its 200-day average ($0.89).
- 52-week range $0.44–$1.32; today's close sits at 6% of that range, 62.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — ONCY slides 16.1% to $0.47, a 52-week low on 3.7x normal volume
- Closed at $0.47, -16.07% vs the prior close of $0.56. Day range $0.44–$0.59, opened at $0.57.
- Volume was 3.32M shares, 3.7x its 50-day average of 904.54K — unusually heavy trading.
- Price is -38.0% vs its 50-day average ($0.76) and -47.6% vs its 200-day average ($0.90).
- 52-week range $0.44–$1.32; today's close sits at 3% of that range, 64.4% below the 52-week high.
Oct 9, 2026 — ONCY jumps 3.7% to $0.56
- Closed at $0.56, +3.70% vs the prior close of $0.54. Day range $0.53–$0.57, opened at $0.55.
- Volume was 1.46M shares, 1.6x its 50-day average of 895.28K.
- Price is -26.7% vs its 50-day average ($0.76) and -37.7% vs its 200-day average ($0.90).
- 52-week range $0.53–$1.32; today's close sits at 4% of that range, 57.6% below the 52-week high.
Oct 8, 2026 — ONCY slides 10.0% to $0.54, a 52-week low, 7 down days in a row
- Closed at $0.54, -10.00% vs the prior close of $0.60. Day range $0.54–$0.61, opened at $0.60.
- Volume was 1.12M shares, 1.3x its 50-day average of 890.94K.
- Price is -29.7% vs its 50-day average ($0.77) and -40.1% vs its 200-day average ($0.90).
- 52-week range $0.54–$1.36; today's close sits at 0% of that range, 60.3% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 — ONCY ends flat (+0.0%) to $0.60, 6 down days in a row
- Closed at $0.60, +0.00% vs the prior close of $0.60. Day range $0.58–$0.61, opened at $0.59.
- Volume was 669.00K shares, 0.7x its 50-day average of 894.90K.
- Price is -22.3% vs its 50-day average ($0.77) and -33.6% vs its 200-day average ($0.90).
- 52-week range $0.58–$1.39; today's close sits at 2% of that range, 56.8% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — ONCY ends flat (+0.0%) to $0.60, 5 down days in a row
- Closed at $0.60, +0.00% vs the prior close of $0.60. Day range $0.58–$0.61, opened at $0.60.
- Volume was 858.50K shares, 1.0x its 50-day average of 896.60K.
- Price is -22.6% vs its 50-day average ($0.78) and -33.7% vs its 200-day average ($0.91).
- 52-week range $0.58–$1.42; today's close sits at 2% of that range, 57.7% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: DEF 14A.
Oct 5, 2026 — ONCY slides 4.8% to $0.60, a 52-week low on 2.2x normal volume
- Closed at $0.60, -4.76% vs the prior close of $0.63. Day range $0.58–$0.64, opened at $0.64.
- Volume was 1.94M shares, 2.2x its 50-day average of 874.42K — unusually heavy trading.
- Price is -23.0% vs its 50-day average ($0.78) and -33.9% vs its 200-day average ($0.91).
- 52-week range $0.58–$1.42; today's close sits at 2% of that range, 57.7% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — ONCY dips 1.6% to $0.63, a 52-week low, 3 down days in a row
- Closed at $0.63, -1.56% vs the prior close of $0.64. Day range $0.62–$0.65, opened at $0.65.
- Volume was 609.30K shares, 0.7x its 50-day average of 883.58K.
- Price is -19.6% vs its 50-day average ($0.78) and -30.7% vs its 200-day average ($0.91).
- 52-week range $0.62–$1.47; today's close sits at 1% of that range, 57.1% below the 52-week high.
- That makes 3 straight losses.
ONCY latest news & SEC filings
Every SEC filing by or about ONCY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 6, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$9.44M (prior year -$5.28M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.06) (loss widened vs Jun 30, 2025)
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Things to know before you trade ONCY
- How much it moves: over the last 20 sessions the average daily move was 3.67% (largest 16.1%). That is a volatile stock.
- Liquidity: about 1.46M shares (≈$805.24K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.55 vs a range of $0.44–$1.32 (13% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 14 open-market buys, 0 sales; latest: Jared Kelly bought 5,050 shares on Mar 12, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 13, 2026; 8-K Sep 29, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ONCY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.55 | 0.59 | 0.52 | 0.55 | 1.30M |
| Oct 14, 2026 | 0.50 | 0.56 | 0.44 | 0.54 | 3.15M |
| Oct 13, 2026 | 0.49 | 0.50 | 0.45 | 0.49 | 4.20M |
| Oct 12, 2026 | 0.57 | 0.59 | 0.44 | 0.47 | 3.32M |
| Oct 9, 2026 | 0.55 | 0.57 | 0.53 | 0.56 | 1.46M |
| Oct 8, 2026 | 0.60 | 0.61 | 0.54 | 0.54 | 1.12M |
| Oct 7, 2026 | 0.59 | 0.61 | 0.58 | 0.60 | 669.00K |
| Oct 6, 2026 | 0.60 | 0.61 | 0.58 | 0.60 | 858.50K |
| Oct 5, 2026 | 0.64 | 0.64 | 0.58 | 0.60 | 1.94M |
| Oct 2, 2026 | 0.65 | 0.65 | 0.62 | 0.63 | 609.30K |
| Oct 1, 2026 | 0.67 | 0.68 | 0.63 | 0.64 | 689.80K |
| Sep 30, 2026 | 0.68 | 0.68 | 0.65 | 0.67 | 867.00K |
| Sep 29, 2026 | 0.67 | 0.68 | 0.66 | 0.67 | 779.00K |
| Sep 28, 2026 | 0.68 | 0.72 | 0.66 | 0.66 | 1.13M |
| Sep 25, 2026 | 0.69 | 0.69 | 0.67 | 0.68 | 822.00K |
| Sep 24, 2026 | 0.68 | 0.69 | 0.64 | 0.68 | 1.21M |
| Sep 23, 2026 | 0.73 | 0.73 | 0.66 | 0.68 | 1.89M |
| Sep 22, 2026 | 0.76 | 0.78 | 0.71 | 0.71 | 2.08M |
| Sep 21, 2026 | 0.77 | 0.79 | 0.76 | 0.77 | 693.30K |
| Sep 18, 2026 | 0.78 | 0.78 | 0.76 | 0.77 | 491.50K |
About Oncolytics Biotech
Oncolytics Biotech (ONCY) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1129928.
ONCY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Patricia S Andrews | Director | Jun 3, 2026 |
| Deborah Margaret Brown | Director | Jun 3, 2026 |
| Stephen C. Glover | Director | Jun 3, 2026 |
| Angela Holtham | Director | Jun 3, 2026 |
| Jared Kelly | Chief Executive Officer | Jun 3, 2026 |
| James T. Parsons | Director | Jun 3, 2026 |
| Wayne Pisano | Director | Jun 3, 2026 |
| Jonathan Rigby | Director | Jun 3, 2026 |
| Bernd R. Seizinger | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Andrew Aromando | Chief Business Officer | Jun 3, 2026 |
| Allison Hagerman | Chief Technology Officer | Jun 3, 2026 |
| Thomas Charles Heineman | Chief Medical Officer | Jun 3, 2026 |
| Jared Kelly | Chief Executive Officer | Jun 3, 2026 |
| Kirk Look | Chief Financial Officer | Jun 3, 2026 |
| John Bearden Mcadory | Chief Operating Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 12, 2026 | Jared Kelly | Buy | 5,050 | $0.96 |
| Mar 11, 2026 | James T. Parsons | Buy | 10,000 | $1.03 |
| Feb 12, 2026 | Deborah Margaret Brown | Buy | 25,000 | $0.85 |
| Feb 12, 2026 | Kirk Look | Buy | 12,000 | $0.84 |
| Feb 12, 2026 | Patricia S Andrews | Buy | 35,400 | $0.86 |
| Feb 12, 2026 | Jared Kelly | Buy | 29,500 | $0.84 |
| Feb 12, 2026 | Bernd R. Seizinger | Buy | 40,000 | $0.85 |
| Feb 12, 2026 | Allison Hagerman | Buy | 10,000 | $0.83 |
| Feb 12, 2026 | Wayne Pisano | Buy | 30,000 | $0.84 |
| Feb 12, 2026 | Thomas Charles Heineman | Buy | 12,132 | $0.83 |
| Feb 11, 2026 | Jared Kelly | Buy | 5,600 | $0.84 |
| Feb 11, 2026 | Bernd R. Seizinger | Buy | 60,000 | $0.83 |
| Feb 11, 2026 | Andrew Aromando | Buy | 29,600 | $0.86 |
| Jan 16, 2026 | Bernd R. Seizinger | Buy | 100,000 | $1.04 |
ONCY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-28.76M | -0.30 | $-20.11M |
| Dec 31, 2024 | — | $-22.79M | -0.30 | $-19.88M |
Latest balance sheet: total assets $7.67M, total liabilities $13.84M, cash $4.12M (as of Jun 30, 2026).
ONCY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ONCY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.